- Home
- HCSG
HCSG
Healthcare Services Group Inc.
as 07-26-2024 4:00pm EST
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | BENSALEM |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $14.50 | AVG Volume (30 days): | 749.5K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.57 | EPS Growth: | 23.91 |
| 52 Week Low/High: | $8.75 - $13.01 | Next Earning Date: | 07-24-2024 |
| Revenue: | $1,677,592,000 | Revenue Growth: | -0.18% |
| Revenue Growth (this year): | 4.76% | Revenue Growth (next year): | 3.20% |
Stock Insider Trading Activity of Healthcare Services Group Inc. (HCSG)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Brophy Andrew M | HCSG | Principal Accounting Officer | Feb 28 '24 | Sell | $12.58 | 1,125 | $14,152.50 | 7,741 | SEC Form 4 |
Latest Healthcare Services Group Inc. News
HCSG Breaking Stock News: Dive into HCSG Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
UBS Adjusts Healthcare Services Group Price Target to $12 From $13, Maintains Neutral Rating
Associated Press Finance
3 days ago
Healthcare Services: Q2 Earnings Snapshot
Business Wire
3 days ago
HCSG Reports Q2 2024 Results
Argus Research
3 days ago
HCSG: What does Argus have to say about HCSG?
Argus Research
10 days ago
HCSG: Raising target price to $12.00
Simply Wall St.
12 days ago
Healthcare Services Group (NASDAQ:HCSG) Will Be Hoping To Turn Its Returns On Capital Around
Argus Research
17 days ago
HCSG: Lowering target price to $11.00
Simply Wall St.
a month ago
Is Healthcare Services Group, Inc.'s (NASDAQ:HCSG) Recent Price Movement Underpinned By Its Weak Fundamentals?
Compare HCSG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCSG Healthcare Services Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.